GoldBamboo.com - Knowledge is strong medicine
  

Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy - Article


  Not Signed In - Sign In / Register






Gabapentin

Neurontin


Clinical Trial: Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy

This study is not yet open for patient recruitment.
Verified by Hvidovre University Hospital September 2005

Sponsored by: Hvidovre University Hospital
Information provided by: Hvidovre University Hospital
ClinicalTrials.gov Identifier: NCT00209885

Purpose

To test the current standard of care (SOC) treatment for laparoscopic cholecystectomy with a group receiving SOC + additional perioperative analgesics in terms of postoperative abilities, PONV, pain and discharge time from the PACU
Condition Intervention Phase
Cholecystolithiasis
 Drug: Gabapentin
 Drug: S-ketamine
 Drug: Lidocaine
 Drug: Droperidol
Phase IV

MedlinePlus related topics:  Gallbladder Diseases

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study

Further Study Details: 
Primary Outcomes: 1. postoperative abilities over time in PACU; 2. discharge time from PACU according to fixed criteria; 3. consumption of analgesics and antiemetics in the PACU
Secondary Outcomes: 1. Degree of nursing requirements in the PACU; 2. General tolerability of the regimens
Expected Total Enrollment:  60

Study start: October 2005

Aim of the study: to compare postoperative complaints (PONV, pain, etc) and PACU discharge time between two groups:

  • A: standard of care (SOC)receiving intraoperative dexamethasone, ondansetron, ketorolac, and general anaesthesia with propofol, remifentanil and cisatracurium
  • B: SOC + preoperative gabapentin, intraoperative lidocain infusion, s-ketamin and droperidol.

Primary endpoints:

  • postoperative abilities over time
  • discharge time from PACU according to fixed criteria
  • consumption of analgesics and antiemetics in the PACU

Secondary endpoints:

  • degree of nursing requirements at the PACU
  • General tolerability of the regimes

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both
Criteria

Inclusion Criteria:

  • Elective laparoscopic cholecystectomy
  • Age above 18 years
  • Written informed consent
  • ASA class I-III

Exclusion Criteria:

  • Planned abdominal cholecystectomy
  • Intraoperative conversion of laparoscopic to laparotomic cholecystectomy
  • Allergy to part of the treatment regimens
  • Previous reactions to opioids (nausea, cognition)

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00209885

Kenneth Jensen, M.D.      +45 36 32 62 90    kenneth.jensen@hh.hosp.dk

Denmark, Hvidovre
      Dept of Anaesthesia, Hvidovre Hospital, Copenhagen,  Hvidovre,  2650,  Denmark
Kenneth Jensen, M.D.  +45 36 32 62 90    kenneth.jensen@hh.hosp.dk 
Kenneth Jensen, M.D.,  Principal Investigator

Study chairs or principal investigators

Kenneth Jensen, M.D.,  Principal Investigator,  Dept of Anaesthesia, Acute Pain Service, Hvidovre Hospital, Copenhagen, Denmark   
Claus Lund, dr.med.sci,  Study Chair,  Dept of Anaesthesia, Hvidovre Hospital, Copenhagen, Denmark   

More Information

Study ID Numbers:  OMA-LC01
Last Updated:  September 20, 2005
Record first received:  September 14, 2005
ClinicalTrials.gov Identifier:  NCT00209885
Health Authority: Denmark: Danish Medicines Agency
ClinicalTrials.gov processed this record on 2005-09-27


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Gabapentin.

October 6, 2008



Page Updated: June 1, 2005
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Massachusetts Law | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.